chrisvoncsefalvay/vaers-outcomes huggingface dataset:
1-2 weeks after the second vaccination, pt. began experiencing fatigue, headache, muscle aches. He then developed a rash all over his body, and sores on his tongue. Then he developed a fever, was unable to leave his bed, passed out multiple times, and was eventually admitted to the hospital with a 105 degree fever and pneumonia on the morning of July 10th. They could not keep his blood pressure up and put him on three different drugs to keep him alive, and by the end of July 10th, just 12 hours after he was admitted, he was put on a ventilator because he was not able to breathe on his own anymore. His white blood cell count was 0.2, and every time they changed the IV bags and momentarily discontinued the BP medicine, he would drop to critical levels. On the second day they were fairly sure he was not going to make it, but he has since gotten a little better. They have been giving him blood transfusions and platelets. He has remained on a ventilator for 18 days now, and has developed fevers every afternoon, up to 102 degrees, which they keep bringing down again with medication and ice.   They have tested him for practically ever disease known to man for 18 days. There is no cause they can find. Not cancer, not autoimmune disease, nothing. Pt. has not been to the hospital since he was a child and it was for injury, not illness. He has never had any sort of major disease or cancer or chronic illness. The hospital or me, his mother, can be contacted for any further questions.
A report has been received from a Physician concerning, subject of unknown gender, who had been receiving FLUMIST QUADRIVALENT (intranasal). FLUMIST QUADRIVALENT started on 17-Jan-2014. The patient experienced expired FLUMIST QUADRIVALENT administered which started on 17-Jan-2014. The outcome of the event of expired FLUMIST QUADRIVALENT is unknown. The reported was considered to be non-serious.
Information has been received from a RN concerning her 9 yr old son with scoliosis secondary to Friedreich's ataxia who on 18Aug97 was vaccinated with a dose of varicella virus vaccine live (lot622750/0545E). Concomitant therapy included antioxidants (unspecified). In Dec 2005, the pt experienced chickenpox. Unspecified medical attention was sought. It was reported that the pt normally wears a brace for scoliosis, however he has been unable to wear the brace due to the varicella lesions and it is very difficult for the pt to walk without his brace. At the time of the report, the lesions were now crusted into scabs and he was recovering. Follow up information from the physician indicated that the pt had no reaction, had varicella 7 years post vaccination. Chickenpox was considered to be disabling by the pt's mother. No further information was expected.
Initial report received on 3/23/2006 from a health care provider. A 52 year old female patient had received a subcutaneous injection of IPOL, lot number Y0824-2, in the right deltoid on 3/20/2006 at 8:45. 30 minutes later, she developed what felt like a lump on her tongue. She was seen by her primary care physician and treated with Claritin, Singular and prednisone. Her symptoms resolved forty five minutes later. When she stopped taken the prescribed medications the symptoms returned. At the time of this report the patient had not recovered from this event.
Itchy, red , swollen and sore at the site of the injection 10 days following the vaccine.
I started burning so bad, it burns so bad that It was ring in my hands, It was like my whole body was all burn, my blood stream was something even down my feet was burning so bad I couldn't stand; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 75-year-old patient received BNT162b2 (BNT162B2), on 22Sep2022 as dose number unknown (booster), single (Batch/Lot number: unknown) at the age of 75 years for covid-19 immunisation. The patient's relevant medical history included: "Blood pressure" (unspecified if ongoing), notes: Blood pressure. Concomitant medication(s) included: ADVIL [IBUPROFEN]; ZOLOFT. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete, unknown manufacturer), for COVID-19 Immunization. The following information was reported: BURNING SENSATION (non-serious) with onset 23Sep2022, outcome "unknown", described as "I started burning so bad, it burns so bad that It was ring in my hands, It was like my whole body was all burn, my blood stream was something even down my feet was burning so bad I couldn't stand". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of burning sensation.  Additional information: Patient took the Pfizer shot, the booster (Clarified as Pfizer COVID-19 Vaccine) and took it on Thursday at 8 O' clock, Thursday night and came home, patient had done real good and then at 1 O' clock the next day, I started burning so bad. Patient was 75 years old and was strong, patient worked outside, and it burns so bad that It was ring in my hands walk on the floor. It lasted about 7 or 8 hours. It was like whole body was all burn, my blood stream was something even down my feet was burning so bad patient couldn't stand it.  When paraphrased the concern: Consumer stated, "Yes, it was bad, somebody is not healthy as patient. Patient did not knew what they would have done but would never take another one. Patient did not had, the expiration date. Its the top the first one patient took was the expiration date on it but did not have the expiration date that on the other three. It says Pfizer 37J25W and other one says WAGF659. W is what look likes or 2, it got it scribbled on it there. Other medications: Consumer stated, "Sugar Pills (Name not clarified hence, not captured in tab) and then Blood pressure." Lab test: Consumer stated, "I had COVID two months ago (Further clarifications unknown if consumer took the Pfizer COVID-19 Vaccine as his previous shot hence, PC not filed) and it was nearest bad is what I experienced, Nothing is wrong with me, No, I don't know what you are saying." (Further clarifications unknown hence, tab left unchecked)." Treatment: Consumer stated, "I took extra Tylenol  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
a lump next to it after having the vaccine; I have a swelling in my arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (a lump next to it after having the vaccine) and VACCINATION SITE SWELLING (I have a swelling in my arm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE MASS (a lump next to it after having the vaccine) and VACCINATION SITE SWELLING (I have a swelling in my arm). At the time of the report, VACCINATION SITE MASS (a lump next to it after having the vaccine) and VACCINATION SITE SWELLING (I have a swelling in my arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitants medication were provided. No treatment medication were provided. No lab data has been provided by the reporter.
This is a spontaneous report received from a contactable consumer or other non-HCP. A patient (no qualifiers provided) received the 3rd (booster) dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# unknown), single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications not reported. Vaccination history included the 1st and 2nd dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine), for COVID-19 immunisation. The patient experienced illness (outcome unknown). Additional information: Reporter stated four people just got the booster and they are still sick four days later from Pfizer. Follow-up attempts completed. No further information expected.
3 - 5 min. after vaccines (HPV,flu shot, TST) client felt a warm flush, passed out and slid to the floor from her chair, bumped head RT side - no swelling.
pain all over my body; skin is itchy on diferents parts/I'm having ants inside my body; Its so stressful; This case was reported by a consumer via interactive digital media and described the occurrence of general body pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   In November 2021, the patient received the 1st dose of Shingles vaccine. In November 2021, less than a week after receiving Shingles vaccine, the patient experienced general body pain, generalized pruritus and stress. On an unknown date, the outcome of the general body pain, generalized pruritus and stress were not recovered/not resolved.   It was unknown if the reporter considered the general body pain, generalized pruritus and stress to be related to Shingles vaccine.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient got the first Shingles vaccine 3 days ago and he/she did not even know about this.  The patient had pain in all his/her body and skin was itchy on different parts, it was like "having ants inside body".  The physician did not find the cause it was horrible and so stressful.
ON 8/30/19 the patient reported that She got her second shingles vaccine on 8/27/19 She claimed that she developed hives all over her body on 8-29-19 and itching on the morning of 8-30-19. Patient also said that she had fever, swelling and soreness on the site of injection (deltoid left arm). She reported that she does not have swelling in her throat or difficulty breathing but has throat pain when she drinks water.  I advised patient to seek emergency care immediately. She said she will head over to urgent care that morning
Client came to the vaccine clinic with no complaints according to the vaccine check sheet. After the vaccine was administered he told a worker that he was having chest pain. Upon examination he stated that he was having chest pain before he came to the clinic this morning and that he gets the chest pain on a frequent basis. He had a stress test yesterday that was not reported until after the vaccine was administered.
itching; redness; hives; other people have a rash that didn't start until a week after the Moderna shot; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching), ERYTHEMA (redness), URTICARIA (hives) and RASH (other people have a rash that didn't start until a week after the Moderna shot) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 034c21a and 048c21a) for COVID-19 vaccination.     Concurrent medical conditions included Breast cancer, Osteoporosis and Leg cramps. Concomitant products included LETROZOLE for Breast cancer, MAGNESIUM for Leg cramps, ALENDRONATE SODIUM, COLECALCIFEROL (FOSAMAX D) for Osteoporosis, FOLIC ACID and COLECALCIFEROL (D3) for an unknown indication.   On 20-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Aug-2021, the patient experienced PRURITUS (itching), ERYTHEMA (redness), URTICARIA (hives) and RASH (other people have a rash that didn't start until a week after the Moderna shot). The patient was treated with HYDROCORTISONE VALERATE (HYDROCORTISONE [HYDROCORTISONE VALERATE]) from 19-Aug-2021 to 23-Aug-2021 for Adverse event, at a dose of UNK, tid. On 23-Aug-2021, PRURITUS (itching), ERYTHEMA (redness), URTICARIA (hives) and RASH (other people have a rash that didn't start until a week after the Moderna shot) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications was reported.  Treatment information was not provided.   This case was linked to MOD-2021-269939.   Most recent FOLLOW-UP information incorporated above includes: On 17-Sep-2021: Follow-up was received on 17-SEP-2021 and patient demographic details, patient gender, concomitant medication, suspect product details, Treatment information and new events, causality were added.
Congestion in lungs; Upper respiratory infection; Felt passed out; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PULMONARY CONGESTION (Congestion in lungs) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A24A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced PULMONARY CONGESTION (Congestion in lungs) (seriousness criterion medically significant), UPPER RESPIRATORY TRACT INFECTION (Upper respiratory infection) and PRESYNCOPE (Felt passed out). At the time of the report, PULMONARY CONGESTION (Congestion in lungs), UPPER RESPIRATORY TRACT INFECTION (Upper respiratory infection) and PRESYNCOPE (Felt passed out) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Patient had fever, chills, headache and sore throat. Then later she developed cough with mucus and shortness of breath. She still had congestion in lungs and at one time almost felt passed out. She has been to emergency 4 times for this and they told her that it was upper respiratory infection. Treatment medications included Loratadine, Dexamethasone and Albuterol.
Information has been received from a medical assistant referring to an 8 week old female patient. No relevant medical history or concurrent conditions were reported. On 09-JUN-2015, the patient was inadvertently vaccinated with improperly stored ROTATEQ (lot # K014826, expiration date 28-MAY-2016; dose was not reported) orally. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
first dose of SHINGRIX in December, 2019. The patient received the second dose of SHINGRIX yesterday (July 27, 2023); very sore arm (Left); This non-serious case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 83-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of influenza like illness (1st dose received on December 2019, and felt achy reference case US2023103539).   On 27-JUL-2023, the patient received the 2nd dose of Shingrix. In JUL-2023, an unknown time after receiving Shingrix, the patient experienced pain in arm (Verbatim: very sore arm (Left)). On 27-JUL-2023, the patient experienced drug dose administration interval too long (Verbatim: first dose of SHINGRIX in December, 2019. The patient received the second dose of SHINGRIX yesterday (July 27, 2023)). The outcome of the pain in arm was not resolved and the outcome of the drug dose administration interval too long was unknown.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.     It was unknown if the company considered the pain in arm to be related to Shingrix.   Linked case(s) involving the same patient:  US2023103539   Additional Information: GSK receipt date: 28-Jul-2023 The patient received the 2nd dose of Shingrix yesterday (the day before reporting) and had a very sore arm (left). The patient received 2nd dose after the schedule date, which led to lengthening of vaccination schedule. The reporter consented to follow up with the health care professionals (HCP) of pharmacy.; Sender's Comments:  US-GSK-US2023103539:Case for 1st dose
Patient with vomiting the evening after giving the vaccination. With dehydration and had to go to ER for rehydration by IV.
pt. reported @ 1:30 pm that she felt dizzy. Vital signs initiated pt. stated @ 1:40 pm she felt her heart racing. Pt. vital signs closely monitored. Pt. repositioned at 2:50 pt reported she felt "something in my throat".  25 mg Benadryl administered IM Rt Deltoid  at 3:05pm EMS called- pt was taken to Hospital at 3:08pm by paramedics. Pt was alert and oriented X3 when leaving facility. Pt was safely escorted by medical staff to  Hospital for further evaluation. Pt was oted to have HR 111. O2 sat 97% when leaving facility.
Information has been received from a registered nurse regarding a patient of unknown age and gender. On 17-JAN-2013 at 07:45, ZOSTAVAX lot # H019999 was exposed to -14C for an estimated total time out of range of 14-25 hours. On 30-JAN-2013 at 18:00, ZOSTAVAX lot # H019999 was exposed to -14C for an estimated total time out of range of 10.5 hours. On 12-MAR-2013 at 17:00, ZOStAVAX lot # H019999 was exposed to -14C for an estimated total time out of range of 9.25 hours. On 13-MAR-2013 at 18:00, ZOStAVAX lot # H)19999 was exposed to -14C for an estimated total time out of range of 10.5 hours. On 19-MAR-2013, the patient was vaccinated with an out of range dose of ZOSTAVAX (dose and route administration were not provided) (Lot number H019999). No adverse experience had been reported. This is one of 182 reports from the same source. Additional information has been requested.
1/15/2021, 8:15 AM Approx. 10 minutes after arising,  experienced dizziness, nausea, unwell feeling, cold sweat.  Lasted approx. 20 minutes.  Resolved after lying down..
difficult, felt like a knot under the skin; very sore, from injection site to the wrist, severe thing that's happened in my life, brought me to my knees; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION (difficult, felt like a knot under the skin) and VACCINATION SITE PAIN (very sore, from injection site to the wrist, severe thing that's happened in my life, brought me to my knees) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044A21A and 030MZ0A) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included DULOXETINE HYDROCHLORIDE (CYMBALTA) and CLOPIDOGREL BISULFATE (PLAVIX) for an unknown indication.   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 14-Mar-2021, the patient experienced VACCINATION SITE PAIN (very sore, from injection site to the wrist, severe thing that's happened in my life, brought me to my knees). On 02-May-2021, the patient experienced VACCINATION SITE INDURATION (difficult, felt like a knot under the skin). The patient was treated with IBUPROFEN in May 2021 for Adverse event, at a dose of 1 dosage form. At the time of the report, VACCINATION SITE INDURATION (difficult, felt like a knot under the skin) and VACCINATION SITE PAIN (very sore, from injection site to the wrist, severe thing that's happened in my life, brought me to my knees) outcome was unknown.            No Patient lab data was provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-101830 (Linked Report).   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 08-Jul-2021: Follow-up received and No New Information.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-101830:Neighbor's case
10 days after 2nd Moderna vaccine -pain in right breast spreading to rest of breast continuing into breast bone and under right arm. Sometimes pain when area touched then often became severe and difficult to raise arm.  Fatigue .
Fever on day 5 and 6 after vaccine administered.  Rash appeared on day 8 (05/11/2010), on back, chest, face.  The rash lasted for 4 days.
She tested positive for COVID-19 following the first dose; She tested positive for COVID-19 following the first dose; This is a spontaneous report from a contactable healthcare professional. A 27-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EJ1686, expiration date:Mar2021), via an unspecified route of administration (left arm) on 12Jan2021 at a single dose for COVID-19 immunization. The patient's medical history was not reported. There were no concomitant medications. The patient was asking when she can receive the second dose of the COVID vaccine if she tested positive for COVID-19 following the first dose. She received the first dose of the vaccine on 12Jan2021 and tested positive for COVID-19 on 14Jan2021. The patient underwent lab tests and procedures which included POC rapid COVID test: two negative tests on unspecified date, before getting the vaccine, she is tested twice weekly for work, and positive on 14Jan2021. The outcome of the events was not recovered.; Sender's Comments: Based on the information currently available, lack of efficacy of the suspected vaccine BNT162B2 cannot be completely excluded. However, individuals may not be protected until at least 7 days after their second dose of the vaccine. It is unlikely that the patient would have fully developed immunity due to the very short time lag between the first vaccine dose and the event onset.
This spontaneous report was received from a pharmacist, and refers to a female patient of unknown age. The patient had no concomitant medications, medical history and no drug reactions/allergies. No information about the patient's concurrent conditions was provided. On 30-JAN-2018, the patient was vaccinated with a dose of PNEUMOVAX 23 injection, for vaccination, (dose, frequency, route, strength, lot number and expiration date were not provided). On 30-JAN-2018 (reported as last night), the patient developed "redness and warmth at the injection site last night, which has now moved to a different part of the same arm today". Furthermore, it was reported that the patient sought medical attention by calling the pharmacist but it was reported that no treatment was prescribed and no laboratories were performed. At the time of reporting, the outcome of injection site erythema and injection site warmth was reported as not recovered. The causal relationship between PNEUMOVAX 23 and the reported events was not provided.
I received my 1 booster shot on 11/16/2021 and my adverse event started on 04/26/2022 I woke up in the morning not feeling good (not 100%) as the day went by I started feeling worse. I was at work and I had come home. I laid down and that evening I took a COVID test which was positive. I called my doc through tele health and I told her about my situation  and what I was taking. She said I was doing the right. I was taking Mucinex to treat my symptoms. I treated like as a cold. I drank soups, a lot of liquid, Gatorade, etc. I tested 10 days after the event and was negative.